A First-in-Human, Phase 1a/1b Trial to Assess the Safety, Tolerability and Preliminary Efficacy of LY4170156, an Antibody-Drug Conjugate Targeting Folate Receptor α-Expressing Tumor Cells, in Participants With Selected Advanced Solid Tumors
Status: Recruiting
Location: See all (24) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-expansion). The study will last up to approximately 4 years.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Have one of the following solid tumor cancers:
‣ Cohort A1: Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer, endometrial cancer, cervical cancer, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), pancreatic, and colorectal cancer (CRC)
⁃ Cohort A2/A3/A4/A5/B1/B2: Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer
⁃ Cohort C1/C2: Endometrial cancer, cervical cancer, NSCLC, TNBC, CRC or pancreatic cancer
Locations
United States
Arizona
HonorHealth
RECRUITING
Scottsdale
California
University of California, San Diego (UCSD) - Moores Cancer Center
RECRUITING
La Jolla
Massachusetts
Dana-Farber Cancer Institute
NOT_YET_RECRUITING
Boston
Michigan
South Texas Accelerated Research Therapeutics (START) Midwest
RECRUITING
Grand Rapids
New York
NYU Langone Health - Long Island
RECRUITING
Mineola
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
RECRUITING
New York
New York University (NYU) Clinical Cancer Center
RECRUITING
New York
Ohio
The Ohio State University (OSU) Wexner Medical Center
RECRUITING
Columbus
Texas
The University of Texas - MD Anderson Cancer Center
RECRUITING
Houston
Utah
START Mountain Region
RECRUITING
West Valley City
Other Locations
Australia
Cancer Research SA
RECRUITING
Adelaide, Sa
Icon Cancer Centre South Brisbane
RECRUITING
Qld
France
Centre Leon Berard
RECRUITING
Lyon
Institut de Cancerologie de l'Ouest - site St-Herblain
RECRUITING
Saint-herblain
Oncopole Claudius Regaud
RECRUITING
Toulouse
Italy
Istituto Europeo di Oncologia
RECRUITING
Milan
Istituto Clinico Humanitas
RECRUITING
Rozzano
Japan
Shizuoka Cancer Center
RECRUITING
Shizuoka
Cancer Institute Hospital of JFCR
RECRUITING
Tokyo
National Cancer Center Hospital
RECRUITING
Tokyo
Republic of Korea
National Cancer Center
RECRUITING
Goyang-si Gyeonggi-do
Spain
Hospital Universitario Vall d'Hebron
RECRUITING
Barcelona
Hospital Universitario 12 de Octubre
RECRUITING
Madrid
Hospital Clinico Universitario de Valencia
RECRUITING
Valencia
Contact Information
Primary
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or